N-[3-FLUORO-4-({6-(METHYLOXY)-7-[(3-MORPHOLIN-4-YLPROPYL)OXY]QUINOLIN-4-YL}OXY)PHENYL]-N`-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE FOR THE TREATMENT OF CANCER

摘要

The present invention provides a compound which is represented by the following structure:
which inhibits, regulates and/or modulates kinase receptors, particularly c-Met, KDR, c-Kit, flt-3 and flt-4. This compound is therefore suitable for the treatment of diseases or disorders associated with uncontrolled, abnormal and/or unwanted cellular activities.